AI in Mental Health, Consciousness Studies, and Equitable Healthcare Access
E409 • Apr 13, 2026 • 14 minsIn this episode, Dr. Chi-Ming Chow explores the concept of digital folie à deux and the role of AI in psychiatric and mental health settings. He discusses how simulated empathy can alter patient narratives and the importance of addressing AI interactions in healthcare conversations. The episode also examines the design of AI for mental health, highlighting ethical considerations. Dr. Chow shifts focus to consciousness in vegetative state patients, followed by a discussion on air pollution, its health concerns, ongoing research, and mitigation strategies. He also covers colon cancer screening efforts for the homeless in Nova Scotia, emphasizing the need for equitable healthcare access. The episode wraps up with a summary and closing remarks.
Peptide Drug Risks, Plant-Based Diet Insights, and Vaccine Efficacy Studies
E408 • Apr 10, 2026 • 20 minsIn this episode, Dr. Chi-Ming Chow discusses Health Canada's warning on unauthorized peptide drugs and regulatory actions taken. He analyzes workforce cuts at Ottawa Hospital and their impact on patient care, offering service level recommendations. The episode also covers a study on plant-based diets and dementia risk from the Multiethnic Cohort Study. Dr. Chow explores the "Jessica" social media trend for calming toddlers, sharing expert opinions. Additionally, he reviews a study on calcium supplements, cardiovascular risk, and vitamin D, noting limitations. The episode concludes with insights on high-dose flu vaccines and Alzheimer's risk, emphasizing gender differences and study limitations.
Salt Risks, Bipolar II Insights, and AI in Medical Billing
E407 • Apr 9, 2026 • 9 minsIn this episode, Dr. Chi-Ming Chow provides an overview of salt usage, discussing health risks, gender differences, and lifestyle factors. He shares strategies to reduce salt intake with insights from dietitians and examines the broader health implications of salt consumption. The episode also delves into Bipolar II disorder, exploring health risks, comparisons with other mental health conditions, and the importance of care integration, alongside biological aspects and current research. Dr. Chow discusses the role of AI and chatbots in managing medical bills, highlighting cautions and privacy concerns. The episode concludes with a thoughtful sign-off.
Rare Diseases, HIV PrEP Access, and Innovations in Pediatric Cardiac Surgery
E406 • Apr 8, 2026 • 12 minsIn this episode, Dr. Chi-Ming Chow discusses Celine Dion's battle with stiff-person syndrome, highlighting the importance of raising awareness for rare diseases. He then examines gaps and disparities in HIV PrEP usage among youth, emphasizing the need to improve access for at-risk populations. The episode also covers the recent doctors' strike in England, exploring its causes and potential implications for the healthcare system. Dr. Chow delves into the innovative use of 3D printing in pediatric cardiac surgery, showcasing its transformative potential. The episode concludes with thoughts on the future of medical technology and its impact on patient care.
Thyroid Health, Sedentary Risks, and Mental Health Misinformation
E405 • Apr 7, 2026 • 16 minsIn this episode, Dr. Chi-Ming Chow begins with an overview of thyroid health and the factors leading to levothyroxine discontinuation in older adults, examining study findings and implications for thyroid hormone therapy. He then explores the application of bonsai principles to healthcare system reform. The episode highlights the impact of sedentary behavior on brain health and discusses strategies for reducing dementia risk through mental engagement and physical activity. Dr. Chow also addresses the prevalence of misleading mental health information on social media platforms. The episode wraps up with insights into these pressing health concerns.
Microplastics, Stroke Risk, Peptides, and Weight Loss Strategies
E404 • Apr 6, 2026 • 13 minsIn this episode, Dr. Chi-Ming Chow explores the health risks of microplastics, corporate responsibility, and public education. He also discusses predicting stroke risk after a transient ischemic attack, highlighting risk factors and the brain-heart connection. The rise of injectable peptides is examined, including trends, skepticism, and regulatory challenges, as well as the influence of social media. Expert health advice and insights on routinized eating for weight loss are provided. The episode wraps up with study limitations and final thoughts.
Quebec Funding, Drug Trends, and New Weight-Loss Pill Foundayo
E403 • Apr 3, 2026 • 13 minsIn this episode, Dr. Chi-Ming Chow begins by discussing Quebec's funding for English-speaking patients and its potential impact on healthcare access. He then highlights alarming trends in drug use in the United States, focusing on medetomidine and fentanyl, their risks, clinical effects, and challenges in managing these substances. Dr. Chow explores fluvoxamine as a potential treatment for long COVID, examining ongoing research and findings. The episode introduces the new weight-loss pill Foundayo, sharing clinical trial results, applications, benefits, side effects, and safety considerations. The episode concludes with closing remarks and a preview of tomorrow's topics.
Vaccine Program Changes, Nurse Cuts, and RNA Therapy for Heart Recovery
E402 • Apr 1, 2026 • 15 minsIn this episode, Dr. Chi-Ming Chow discusses recent changes to the Vaccine Injury Compensation Program and its impact on public confidence. He investigates the program's administration and the resulting concerns. The episode addresses nurse position cuts at London Health Sciences Centre, exploring staffing challenges, related lawsuits, and hospital responses. Dr. Chow highlights lobbying efforts for safe staffing ratios and advances in injectable RNA therapy for heart attack recovery. He examines the strain on mothers in pediatric care, its impact on mental health, and potential policy changes. Medicaid reform and telehealth are discussed as solutions to pediatric care failures. The episode concludes with Dr. Chow's sign-off.
Superbug Sniffing Dog, Sleep & Heart Health, and AI Governance in Healthcare
E401 • Mar 30, 2026 • 25 minsIn this episode, Dr. Chi-Ming Chow starts with the retirement of Angus, the superbug-sniffing dog, and his impact on healthcare. He explores a study on sleep and cardiovascular health, providing key research insights. A 30-day walking and strength program with nutrition tips is also introduced. Dr. Chow discusses scaling and deploying autonomous AI in healthcare, focusing on governance, risk controls, and regulatory validation. He highlights AI chatbots in mental health support, sharing Shannon Flaman's experience with Canadian healthcare access disparities. The episode concludes with a call for systemic changes.
Chronic Pain Breakthrough, Ontario Drug Site Closure, and New COVID Variant BA.3.2
E400 • Mar 26, 2026 • 16 minsIn this episode, Dr. Chi-Ming Chow delves into a range of topics. He explores a breakthrough in chronic back pain treatment and new research on parathyroid hormone. The episode also examines Ontario's decision to close supervised drug consumption sites and its public health implications. Dr. Chow updates listeners on the new COVID-19 variant BA.3.2 in the US and its potential impact. Additionally, he discusses the effects of the US oil embargo on the Cuban healthcare system and concludes with insights on the landmark trial against Meta and YouTube regarding social media addiction.
Virtual Healthcare in NB, Dementia Risks, and Drug Promotion Ethics
E399 • Mar 25, 2026 • 20 minsIn this episode, Dr. Chi-Ming Chow introduces the transition to virtual healthcare in New Brunswick and Quebec's proposed mental health legislation, providing insights into regional healthcare developments. He examines a Finnish study linking infections to an increased risk of dementia, highlighting significant findings. The episode includes a segment sponsored by PharmaCare. Dr. Chow discusses Manitoba's budget, noting an increase in healthcare spending alongside changes in affordability measures and tax credits. Additionally, he explores the role of social media influencers in the promotion of prescription drugs. The episode concludes with Dr. Chow's closing remarks.
US Heatwave, Pesticides & Parkinson's, and AI in Patient Care
E398 • Mar 24, 2026 • 17 minsIn this episode, Dr. Chi-Ming Chow introduces the topics with an overview of the current heatwave in the US, examining its historical context, the role of climate change, and resulting health impacts. He discusses recent study findings on pesticide exposure and its connection to Parkinson's disease, along with the current regulatory status. The episode also explores how AI is reshaping patient visits and the challenges faced within healthcare systems. Dr. Chow shares insights from travel nurse Megan Diaz on the functioning of hospital systems. Additionally, he discusses new research linking muscular strength to longevity in older women, providing valuable health insights.
Virtual Health Care, Blood Transfusion Policies, and Men's Mental Health Initiatives
E397 • Mar 23, 2026 • 20 minsIn this episode, Dr. Chi-Ming Chow introduces a range of topics starting with the effectiveness, payment models, and cultural shifts surrounding virtual health care in Canada. He discusses the updated policy by Jehovah's Witnesses regarding blood transfusions, offering insights into its implications. The episode examines sleep quality, highlighting contributing factors and gender differences. Dr. Chow also covers the relocation of nurse practitioners from the US to Canada, exploring the reasons behind this trend. Additionally, he discusses seasonal allergies management in the context of climate change and highlights men's mental health initiatives, like Cowboys Mud Racing. The episode concludes with a wrap-up.
Type 1 Diabetes & Dementia, Beauty Parlor Stroke, and AI in Breast Cancer Screening
E396 • Mar 20, 2026 • 19 minsIn this episode, Dr. Chi-Ming Chow welcomes listeners and delves into recent research on dementia risks in older adults with type 1 diabetes, highlighting key study findings. He explains the phenomenon of beauty parlor stroke syndrome and offers insights into its management. The episode also explores advancements in AI for breast cancer screening, discussing accompanying ethical considerations. Dr. Chow examines Ontario's electronic medical record system and its implications for primary care funding. He concludes by discussing the FDA's approval of Wegovy HD for obesity treatment, before offering his closing remarks and signing off.
MIND Diet & Brain Aging, Healthcare Workforce, and Adult ADHD Trends
E395 • Mar 18, 2026 • 22 minsIn this episode, Dr. Chi-Ming Chow introduces the latest insights on the MIND diet and its impact on brain aging, highlighting recent research findings. He examines the dynamics of the healthcare workforce in North America, discussing current challenges and opportunities. Dr. Chow also explores trends in Canadian health and disability, providing a comprehensive overview of the issues at hand. The episode delves into adult ADHD, focusing on current prescription patterns and their implications. Additionally, Dr. Chow mentions the sponsorship by Microsoft and HealthEx's Copilot Health, before wrapping up with an episode summary.
Primary Care in BC, Marijuana & Mental Health, and GLP-1 for Atrial Fibrillation
E394 • Mar 17, 2026 • 18 minsIn this episode, Dr. Chi-Ming Chow explores the ongoing recruitment efforts aimed at improving primary care access in British Columbia. He then delves into the complex relationship between marijuana use and mental health, discussing its efficacy, potential risks, and alternative treatments. The episode also covers the benefits of GLP-1 receptor agonists for managing atrial fibrillation, comparing their effectiveness to surgical interventions. Finally, Dr. Chow provides insights into early cholesterol treatment and offers management advice to improve patient outcomes.
Mahjong Benefits, Multivitamins & Aging, and Chemotherapy Cognitive Insights
E393 • Mar 13, 2026 • 14 minsIn this episode, Dr. Chi-Ming Chow begins by introducing the cognitive and social benefits of playing mahjong, along with upcoming updates to the game. He then delves into recent findings on multivitamins and their potential role in biological aging, discussing implications for future research. The episode also covers the use of exercise as a strategy to mitigate cognitive impairment related to chemotherapy, highlighting its benefits. Dr. Chow addresses a safety alert concerning compounded medications and examines concerns surrounding the drug tirzepatide. The episode concludes with Dr. Chow's closing remarks and a wrap-up of the discussed topics.
Aging Mindset, Measles in Alberta, and Global Cancer Screening Trends
E392 • Mar 12, 2026 • 23 minsIn this episode, Dr. Chi-Ming Chow discusses new Yale research on how mindset affects aging. He examines Epic Systems' dominance in electronic health records and raises related concerns. Dr. Chow also addresses a measles outbreak in Alberta and vaccination challenges. He explores mosquito evolution and its impact on human migration, covers U.S. water quality issues, EPA regulations, and filtration solutions. Lastly, he highlights the Canadian Cancer Society's call for earlier colorectal cancer screening and global trends in screening guidelines, before concluding the episode.
Exposomics Insights, Ultra-Processed Foods, and Dementia Risk in Women
E391 • Mar 11, 2026 • 14 minsIn this episode, Dr. Chi-Ming Chow introduces the concept of exposomics and recent research findings in this emerging field. He discusses how a multi-omics approach is advancing environmental health studies, offering new insights into complex interactions. The episode highlights the role of exposomics in understanding diseases such as lung cancer and Alzheimer's, as well as its application in disaster response scenarios. Dr. Chow examines the effects of ultra-processed foods on children's behavior, and discusses a new blood test that assesses dementia risk in women. The episode includes a brief message from sponsor Amazon about their healthcare AI assistant, and concludes with Dr. Chow's closing remarks.
Cannabis Effects, Acetaminophen Safety, and Saskatchewan's Healthcare Initiative
E390 • Mar 10, 2026 • 22 minsIn this episode, Dr. Chi-Ming Chow welcomes listeners to another informative session of Morning Medical. He begins by discussing the impact of cannabis compounds and mammograms on liver and cardiovascular health, exploring recent findings. The episode then shifts to the safety of acetaminophen use during pregnancy and efforts to expand the primary care workforce. Dr. Chow highlights Saskatchewan's new healthcare initiative aimed at improving care access. He also examines the role of vitamins in biological aging, offering insights into their potential benefits. The episode concludes with Dr. Chow's closing remarks and a summary of the topics covered.


